Premium
Successful omalizumab treatment in chronic spontaneous urticaria is associated with lowering of serum IL ‐31 levels
Author(s) -
Altrichter S.,
Hawro T.,
Hänel K.,
Czaja K.,
Lüscher B.,
Maurer M.,
Church M.K.,
Baron J.M.
Publication year - 2016
Publication title -
journal of the european academy of dermatology and venereology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.655
H-Index - 107
eISSN - 1468-3083
pISSN - 0926-9959
DOI - 10.1111/jdv.12831
Subject(s) - medicine , omalizumab , medical school , dermatology , allergy , immunology , immunoglobulin e , medical education , antibody